Plasma cell expression list

Flow
Tutorial

Myeloproliferative neoplasms	Neoplasms with eosinophilia (PDGRA/PDGFRB/FGFR1)	MDS/MPN	MDS	AML	Acute leukemia ambiguous lineage
Precursor lymphoid neoplasms	Mature B cell neoplasms	Mature T and NK neoplasms	Hodgkin lymphoma	Immunodeficiency associated lymphoproliferative disorders	Histiocytic and dendritic cell neoplasms

Plasma Cell Neoplasms
	Unusual antigen expression abstracts	Prognostic abstracts	Cytogenetic abstracts	Antigen chart

B cell prolymphocytic leukemia

Splenic B cell marginal zone lymphoma

Splenic B cell lymphoma / leukemia

Heavy chain disease

Nodal marginal zone lymphoma

Primary cutaneous follicle center lymhoma

DLBCL associated with chronic inflammation

Lymphomatoid granulomatosis

Primary mediastinal large B cell lymphoma

ALK positive large B cell lymphoma

Plasmablastic lymphoma

Large B cell lymphoma - HHV8 associated multicentric Castleman

B cell lymphoma, unclassifiable with features of DLBCL and Burkitt

B cell lymphoma, unclassifiable with features of DLBCL and Hodgkin

Article	Antigens evaluated
Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.	CD20, CD45, CD52, CD56, CD117, CD138
Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.	CD10, CD19, CD38, CD138, CD56
Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation.	CD56
The clonal hierachy in multiple myeloma.	CD19, CD38, CD56, CD117
Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells.	CD38, CD117